Lentivi­ral vec­tor ramp-up: J&J and Leg­end to in­vest $500M in New Jer­sey man­u­fac­tur­ing to sup­port Carvyk­ti

In re­sponse to a ques­tion on man­u­fac­tur­ing scale at Leg­end Biotech’s R&D day yes­ter­day, the com­pa­ny’s top ex­ec said its part­ner­ship with John­son & John­son …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER